Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 USD | 0.00% | 0.00% | +62.50% |
2023 | Histogen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Histogen Inc.(OTCPK:HSTO) dropped from NASDAQ Composite Index | CI |
Financials (USD)
Sales 2021 | 1.03M | Sales 2022 | 3.77M | Capitalization | 3.55M |
---|---|---|---|---|---|
Net income 2021 | -15M | Net income 2022 | -10M | EV / Sales 2021 | 2.62 x |
Net cash position 2021 | 13.92M | Net cash position 2022 | 7.48M | EV / Sales 2022 | -1.04 x |
P/E ratio 2021 |
-0.85
x | P/E ratio 2022 |
-0.24
x | Employees | 7 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.15% |
Current month | +38.85% | ||
1 month | +51.52% | ||
3 months | +31.58% | ||
6 months | -35.91% | ||
Current year | +62.50% |
Managers | Title | Age | Since |
---|---|---|---|
Susan Knudson
CEO | Chief Executive Officer | 60 | 20-05-26 |
Mark A. Hubka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas L. Hubka
PRN | Corporate Officer/Principal | 37 | 20-05-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Kisner
CHM | Chairman | 77 | 14-01-31 |
Director/Board Member | 54 | 21-03-24 | |
David Crean
BRD | Director/Board Member | 59 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 0.5 | 0.00% | 1,413 |
24-04-15 | 0.5 | 0.00% | 4,532 |
24-04-12 | 0.5 | 0.00% | 66,129 |
24-04-11 | 0.5 | 0.00% | 4,096 |
24-04-10 | 0.5 | 0.00% | 612 |
Delayed Quote OTC Markets, April 16, 2024 at 12:33 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+62.50% | 2.14M | |
-3.39% | 102B | |
+2.61% | 96.84B | |
-1.02% | 21.48B | |
-18.14% | 20.82B | |
-6.87% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |
- Stock Market
- Equities
- HSTO Stock